一種EGFR/HER2受體酪氨酸激酶抑制劑在製備治療HER2突變癌症藥物中的用途

• 收藏
• 分享

专利权人:

JIANGSU HENGRUI MEDICINE CO., LTD.;江蘇恒瑞醫藥股份有限公司

发明人:

ZOU, Jianjun,ZHOU, Caichun,HUANG, Yaling,REN, Shengxiang,ZHANG, Ge,ZENG, Xiaoling,YANG, Changyong,CAO, Guoqing,ZHANG, Ge,張革,ZENG, Xiaoling,曾曉玲,YANG, Changyong,楊昌永,CAO, Guoqing,曹國慶

申请号：

HK18102974.6

公开号：

HK1243352A

申请日:

2018.03.01

申请国别(地区):

HK

年份:

2018

代理人:

摘要：

The present invention relates to the use of an EGFR/HER2 receptor tyrosine kinase inhibitor in preparing drugs for treating cancers induced by HER2 mutation. In particular, the present invention relates to the use of a compound as shown in formula A or a pharmaceutically acceptable salt thereof in preparing drugs for treating cancers induced by HER2 mutation.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/